Axim Biotechnologies Inc. (OTCMKTS: AXIM) has announced that the CDC has highlighted its sponsored study on neutralizing antibodies in the recent COVID-19 Update: Edition 116. AXIM...
AXIM® Biotechnologies, Inc has submitted its amended Emergency Use Authorization (EUA) application with the US Food and Drug Administration (FDA). The application was first filed in...
Axim Biotechnologies Inc (OTCMKTS:AXIM), an investment company of Medical Marijuana Inc (OTCMKTS:MJNA), rolled out a rapid diagnostic test to measure the levels of neutralizing antibodies and...